---
title: "DOLK"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene Information for DOLK"
tags: ['DOLKgene', 'protein', 'glycosylation', 'CDG1M', 'retinitispigmentosa', 'mutation', 'treatment', 'clinicalstudies']
---

## Gene Information for DOLK

**Function:** The DOLK gene encodes an enzyme that is involved in the biosynthesis of dolichol phosphate, which is a crucial factor in protein glycosylation.

**External IDs and Aliases:**
- HGNC ID: HGNC:30895
- NCBI Entrez Gene ID: 55829
- Ensembl Gene ID: ENSG00000110921
- OMIM ID: 610746
- UniProtKB/Swiss-Prot ID: Q9HCB6

**AA Mutation List:**
| Mutation Type | AA Mutation | dbSNP ID |
| --- | --- | --- |
| Missense | L113F | rs137853214 |
| Missense | D226N | rs760107092 |
| Missense | E303K | rs137853216 |

**Somatic SNVs/InDels with dbSNP ID:**
No somatic SNVs or InDels have been reported for DOLK gene.

**Related Diseases:**
- Congenital disorder of glycosylation type 1M (CDG1M)
- Retinitis pigmentosa, juvenile

**Treatment and Prognosis:**
There is no cure for CDG1M at present, but treatments can ease the symptoms. Treatment may include physical therapy, occupational therapy, speech therapy, medications, and other supportive care.

**Drug Response:**
There is limited information regarding drug response related to DOLK gene.

**Related Papers:**
- Subject: DOLK variants impairing dolichol biosynthesis cause a range of metabolic and clinical presentations including reproductive failure and intellectual disability
  - Author: Al-Sayed et al.
  - DOI: 10.1002/humu.23862
- Subject: DOLK-CDG: Clinical update and report of four novel variants
  - Author: Kerkweg et al.
  - DOI: 10.1002/mgg3.1017

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**